...
首页> 外文期刊>Mutagenesis >Radiation-induced DNA damage and the relative biological effectiveness of 18F-FDG in wild-type mice.
【24h】

Radiation-induced DNA damage and the relative biological effectiveness of 18F-FDG in wild-type mice.

机译:辐射诱导的DNA损伤和18F-FDG在野生型小鼠中的相对生物学有效性。

获取原文
获取原文并翻译 | 示例
           

摘要

Clinically, the most commonly used positron emission tomography (PET) radiotracer is the glucose analog 2-[(18)F] fluoro-2-deoxy-D-glucose ((18)F-FDG), however little research has been conducted on the biological effects of (18)F-FDG injections. The induction and repair of DNA damage and the relative biological effectiveness (RBE) of radiation from (18)F-FDG relative to 662 keV γ-rays were investigated. The study also assessed whether low-dose radiation exposure from (18)F-FDG was capable of inducing an adaptive response. DNA damage to the bone marrow erythroblast population was measured using micronucleus formation and lymphocyte γH2A.X levels. To test the RBE of (18)F-FDG, mice were injected with a range of activities of (18)F-FDG (0-14.80 MBq) or irradiated with Cs-137 γ-rays (0-100 mGy). The adaptive response was investigated 24h after the (18)F-FDG injection by 1 Gy in vivo challenge doses for micronucleated reticulocyte (MN-RET) formation or 1, 2 and 4 Gy in vitro challenges doses for γH2A.X formation. A significant increase in MN-RET formation above controls occurred following injection activities of 3.70, 7.40 or 14.80 MBq (P < 0.001) which correspond to bone marrow doses of ~35, 75 and 150 mGy, respectively. Per unit dose, the Cs-137 radiation exposure induced significantly more damage than the (18)F-FDG injections (RBE = 0.79 ± 0.04). A 20% reduction in γH2A.X fluorescence was observed in mice injected with a prior adapting low dose of 14.80 MBq (18)F-FDG relative to controls (P < 0.019). A 0.74 MBq (18)F-FDG injection, which gives mice a dose approximately equal to a typical human PET scan, did not cause a significant increase in DNA damage nor did it generate an adaptive response. Typical (18)F-FDG injection activities used in small animal imaging (14.80 MBq) resulted in a decrease in DNA damage, as measured by γH2A.X formation, below spontaneous levels observed in control mice. The (18)F-FDG RBE was <1.0, indicating that the mixed radiation quality and/or low dose rate from PET scans is less damaging than equivalent doses of gamma radiation.
机译:在临床上,最常用的正电子发射断层扫描(PET)放射性示踪剂是葡萄糖类似物2-[((18)F]氟-2-脱氧-D-葡萄糖((18)F-FDG)),但是在这方面进行的研究很少(18)F-FDG注射液的生物学效应。研究了(18)F-FDG对662 keVγ射线辐射的DNA损伤的诱导和修复以及相对生物学有效性(RBE)。该研究还评估了(18)F-FDG的低剂量辐射暴露是否能够诱导适应性反应。使用微核形成和淋巴细胞γH2A.X水平测量对骨髓成红细胞群的DNA损伤。为了测试(18)F-FDG的RBE,给小鼠注射一系列(18)F-FDG(0-14.80 MBq)的活性或用Cs-137γ射线(0-100 mGy)照射。在(18)F-FDG注射后24小时,通过1 Gy体内挑战剂量的微核网状细胞(MN-RET)形成或1,2和4 Gy体外挑战剂量的γH2A.X形成来研究适应性反应。在3.70、7.40或14.80 MBq(P <0.001)的注射活性后,与对照组相比,MN-RET的形成显着增加,分别对应于〜35、75和150 mGy的骨髓剂量。与(18)F-FDG注射相比,每单位剂量Cs-137辐射所引起的伤害要大得多(RBE = 0.79±0.04)。相对于对照,在预先注射低剂量的14.80 MBq(18)F-FDG的小鼠中,观察到γH2A.X荧光降低20%(P <0.019)。 0.74 MBq(18)F-FDG注射可以使小鼠的剂量近似于典型的人类PET扫描,但不会引起DNA损伤的明显增加,也不会产生适应性反应。小动物成像(14.80 MBq)中使用的典型(18)F-FDG注射活性导致DNA损伤的减少(通过γH2A.X形成测量)低于对照小鼠中观察到的自发水平。 (18)F-FDG RBE <1.0,表明与PET等效剂量的γ射线相比,PET扫描的混合射线质量和/或低剂量率的破坏性较小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号